Evidence map›Paper›PMID 33952619›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

Local Sustained Delivery of Anti-IL-17A Antibodies Limits Inflammatory Bone Loss in Murine Experimental Periodontitis.

Cinthia M F Pacheco, Katia L M Maltos, Mostafa S Shehabeldin, Laura L Thomas, Zhe Zhuang, Sayuri Yoshizawa, Konstantinos Verdelis, Sarah L Gaffen, Gustavo P Garlet, Steven R Little and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Neutrophils in Inflammatory Bone Diseases.Current osteoporosis reports · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 5 countries.

Cinthia M F PachecoCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-7910-8975
Katia L M MaltosCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-7013-7043
Mostafa S ShehabeldinCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.
Laura L ThomasCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-9729-5081
Zhe ZhuangCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0002-8049-1166
Sayuri YoshizawaCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.
Konstantinos VerdelisCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA.
Sarah L GaffenDivision of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA.ORCID 0000-0001-8511-2041
Gustavo P GarletDepartment of Biological Sciences, Baru School of Dentistry, University of São Paulo, Bauru, Brazil.
Steven R LittleDepartment of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA; and.
Charles SfeirCenter for Craniofacial Regeneration, University of Pittsburgh, Pittsburgh, PA; csfeir@pitt.edu.ORCID 0000-0003-3163-3292
University of Pittsburgh · USUniversidade de São Paulo · BR

Funding

Host and Fungal Regulation of Type 17 Immunity to Oral CandidiasisR37DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sarah L Gaffen · 2017 to 2026
$5.6M
IL-17 Receptor Signaling in the Oral MucosaR01DE022550 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GAFFEN, SARAH L · 2012 to 2016
$2.1M
Treatment of periodontitis by homing M2 macrophagesR21DE025735 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SFEIR, CHARLES · 2016 to 2017
$423k
NIDCR NIH HHS R01 DE022550NIDCR NIH HHS R21 DE025735NIDCR NIH HHS R37 DE022550
6 · The paper itself

Abstract

Periodontal disease (PD) is a chronic destructive inflammatory disease of the tooth-supporting structures that leads to tooth loss at its advanced stages. Although the disease is initiated by a complex organization of oral microorganisms in the form of a plaque biofilm, it is the uncontrolled immune response to periodontal pathogens that fuels periodontal tissue destruction. IL-17A has been identified as a key cytokine in the pathogenesis of PD. Despite its well documented role in host defense against invading pathogens at oral barrier sites, IL-17A-mediated signaling can also lead to a detrimental inflammatory response, causing periodontal bone destruction. In this study, we developed a local sustained delivery system that restrains IL-17A hyperactivity in periodontal tissues by incorporating neutralizing anti-IL-17A Abs in poly(lactic-coglycolic) acid microparticles (MP). This formulation allowed for controlled release of anti-IL-17A in the periodontium of mice with ligature-induced PD. Local delivery of anti-IL-17A MP after murine PD induction inhibited alveolar bone loss and osteoclastic activity. The anti-IL-17A MP formulation also decreased expression of IL-6, an IL-17A target gene known to induce bone resorption in periodontal tissues. This study demonstrates proof of concept that local and sustained release of IL-17A Abs constitutes a promising therapeutic strategy for PD and may be applicable to other osteolytic bone diseases mediated by IL-17A-driven inflammation.

Indexed as

Alveolar Bone LossAnimalsAntibodies, NeutralizingCapsulesDisease Models, AnimalDrug CompoundingDrug Delivery SystemsDrug LiberationInterleukin-17MaleMiceMice, Inbred BALB COsteolysisPeriodontitisPolylactic Acid-Polyglycolic Acid CopolymerTreatment OutcomeAntibodies, NeutralizingCapsulesIl17a protein, mouseInterleukin-17Polylactic Acid-Polyglycolic Acid Copolymer

Identifiers

PMID33952619
PMCPMC10415091
OpenAlexW3158732020

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.